aod9604 clinical trial doses AOD-9604 Before and After: Results December 4, 2024 Pharmacy Compounding
Description
AOD9604 vs MOTS-c: MOTS-c is a mitochondria-derived peptide that has shown promise for metabolic health and fat loss through effects on mitochondrial function and insulin sensitivity
B12 injections can boost your energy and help your body work better
That is an important framing for anyone tempted to treat it as a shortcut: even in the animal work that generates the interest, the compound is one input alongside energy balance, not a replacement for it
Very satisfied
A blood test is the only way to confirm it
They may reduce the risk of heart disease, strokes, and kidney problems
